SAB Biotherapeutics Inc.

SABS | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.48

+$0.09 (+2.65%)

Sep 22, 2026, 10:45 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	13.27M	-34.11M	-42.19M	-18.74M	-17.14M	20.12M
Depreciation & Amortization	3.08M	4.79M	3.75M	3.29M	1.65M	548.18K
Stock-Based Compensation	5.21M	2.94M	2.42M	2.67M	2.31M	1.3M
Other Working Capital	-4.28M	-3.17M	-528.64K	-1.91M	2.06M	584.84K
Other Non-Cash Items	-62.66M	-5.62M	8.58M	-10.45M	3.48M	-2.25K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.69M	-2.3M	2.33M	-237.58K	11.68M	-11.95M
Operating Cash Flow	-44.78M	-34.29M	-25.12M	-23.46M	1.99M	10M
Capital Expenditures	-933.15K	-337.26K	-197.15K	-2.17M	-10.94M	-12.73M
Cash Acquisitions	500	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-142.04M	-37.45M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	21.26M	25.82M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	44.45K	76.39K	n/a	9K
Investing Cash Flow	-121.71M	-11.96M	-152.7K	-2.09M	-10.94M	-12.72M
Debt Repayment	-418.41K	-907K	-390.45K	-1.19M	1.54M	-917.89K
Common Stock Repurchased	n/a	n/a	n/a	-5.52M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-11.96K	-286.04K	59.66M	76.97K	34.34M	-9.9M
Financial Cash Flow	168.3M	-1.17M	66.77M	1.05M	35.89M	8.98M
Net Cash Flow	1.6M	-47.67M	41.52M	-24.5M	26.93M	6.26M
Free Cash Flow	-45.71M	-34.63M	-25.32M	-25.63M	-8.96M	-2.73M
Adj. Free Cash Flow	-50.92M	-37.57M	-27.74M	-28.3M	-11.27M	-4.02M
Maintenance CapEx	-933.15K	-337.26K	-197.15K	-2.17M	-8.03M	n/a
Growth CapEx	n/a	n/a	n/a	n/a	-2.91M	-12.73M
Owner Earnings	-45.71M	-34.63M	-25.32M	-25.63M	-6.04M	10M